Presynaptic modulation by endocannabinoids

Handbook of Experimental Pharmacology

Volumn 184, Issue , 2008, Pages 435-477

  Lovinger, David M ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; ENDOCANNABINOID; NEUROTRANSMITTER UPTAKE INHIBITOR; PRESYNAPTIC RECEPTOR;

ANIMAL; BEHAVIOR; DRUG EFFECT; HUMAN; LONG TERM POTENTIATION; METABOLISM; NERVE CELL PLASTICITY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BEHAVIOR; CANNABINOIDS; ENDOCANNABINOIDS; HUMANS; LONG-TERM POTENTIATION; NEURONAL PLASTICITY; NEUROTRANSMITTER UPTAKE INHIBITORS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, CANNABINOID; RECEPTORS, PRESYNAPTIC; SIGNAL TRANSDUCTION;

EID: 39349101977     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-540-74805-2_14     Document Type: Article

References (245)

1. Abraham WC, Bear MF (1996) Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci 19:126-30
2. Alexander JP, Cravatt BF (2006) The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. J Am Chem Soc 128 (30) :9699-9704
3. Alger BE (2002) Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68:247-86
4. Ameri A, Wilhelm A, Simmet T (1999) Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 126 (8) :1831-9
5. Auclair N, Otani S, Soubrie P, Crepel F (2000) Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83:3287-93
6. Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, ZieglgansbergerW, Rammes G (2004) Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 24 (44) :9953-61
7. Bacci A, Huguenard JR, Prince DA (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431 (7006) :312-16
8. Bachur NR, Masek K, Melmon KL, Udenfriend S (1965) Fatty acid amides of ethanolamine in mammalian tissues. J Biol Chem 240 (3) :1019-24
9. Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D (2004) Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42 (4) :653-63
10. Bass NM (1988) The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol 111:143-84
11. Bazan NG (2005) Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol Neurobiol 32 (1) :89-103
12. Beckstead MJ, Grandy DK,Wickman K,Williams JT (2004) Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42 (6) :939-46
13. Bender VA, Bender KJ, Brasier DJ, Feldman DE (2006) Two Coincidence Detectors for Spike Timing-Dependent Plasticity in Somatosensory Cortex. J Neurosci 26:4166-77
14. Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R (1998) An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity, Eur J Pharm 353 (1) :23-31
15. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, Di Marzo V (1997) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322 ( Pt 2) :671-7
16. Bisogno T, Melck D, De Petrocellis L, Di Marzo V (1999) Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J Neurochem 72 (5) :2113-19
17. Bisogno T, Melck D, Bobrov MY, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V (2000) N-acyl-dopamines: novel synthetic CB (1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J 351 Pt 3:817-24
18. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano Moriello A, Paul P, Gangadharan U, Hobbs C, Di Marzo V, Doherty P (2003) Cloning of the first sn 1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signalling in the brain. J Cell Biol 163:463-8
19. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, Freund TF (2005) Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25:6845-56
20. Bojesen IN, Hansen HS (2003) Binding of anandamide to bovine serum albumin. J Lipid Res 44 (9) :1790-4
21. Bojesen IN, Hansen HS (2005) Membrane transport of anandamide through resealed human red blood cell membranes. J Lipid Res 46 (8) :1652-9
22. Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V, La Rana G, Russo R, Calignano A, Gessa GL, Cuomo V, Piomelli D (2006) Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharm 31 (12) :2652-9
23. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272 (35) :22330-9
24. Bolshakov VY, Siegelbaum S (1994) Postsynaptic induction and presynaptic expression of hippocampal long-term depression. Science 264 (5162) :1148-52
25. Bramham CR, Messaoudi E (2004) BDNF as a trigger for transsynaptic consolidation in the adult brain. In: Stanton PK, Bramham C, Scharfman H (eds) Synaptic plasticity and transsynaptic signaling. Spinger, New York, pp. 159-84
26. Breivogel CS, Selley SE, Childers SR (1998) Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem 273 (27) :16865-73
27. Brenowitz SD, Regehr WG (2005) Associative short-term synaptic plasticity mediated by endocannabinoids. Neuron 45 (3) :419-31
28. Brown SP, Brenowitz SD, Regehr WG (2003) Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids. Nat Neurosci 6:1048-57
29. Brown SP, Safo PK, Regehr WG (2004) Endocannabinoids inhibit transmission at granule cell to Purkinje cell synapses by modulating three types of presynaptic calcium channels. J Neurosci 24 (24) :5623-31
30. Brundege JM, Dunwiddie TV (1996) Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J Neurosci 16:5603-12
31. Burkey TH, Quock RM, Consroe P, Ehlert FJ, Hosohata Y, Roeske WR, Yamamura HI (1997) Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Eur J Pharmacol 336 (2-3) :295-8
32. Calabresi P, Maj R, Mercuri NB, Bernardi G (1992a) Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum. Neurosci Lett 142 (1) :95-9
33. Calabresi P, Maj R, Pisani A, Mercuri NB, Bernardi G (1992b) Long-term synaptic depression in the striatum: physiological and pharmacological characterization, J Neurosci 12:4224-33
34. Calabresi P, Pisani A, Mercuri NB, Bernardi G (1994) Post-receptor mechanisms underlying striatal long-term depression. J Neurosci 14 (8) :4871-81
35. Carlson G, Wang Y, Alger BE (2002) Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 5:723-24
36. Carlsson A (1993) Thirty years of dopamine research. Adv Neurol 60:1-610
37. Castellucci VF, Carew TJ, Kandel ER (1978) Cellular analysis of long-term habituation of the gill-withdrawal reflex of Aplysia californica. Science 202 (4374) :1306-8
38. Cepeda C, Buchwald NA, Levine MS (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci USA 90 (20) :9576-80
39. Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461-72
40. Chevaleyre V, Castillo PE (2004) Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 43 (6) :871-81
41. Chevaleyre V, Hefeits BD, Kaeser P, Sudhof TC, Castillo PE (2006) Endocannabinoids target the release machinery via protein kinase A to mediate LTD at inhibitory synapses in both hippocampus and amygdala. Soc Neurosci Abstr 41. 11
42. Chevaleyre V, Takahashi KA, Castillo PE (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Ann Rev Neurosci 29:37-76
43. Choi S, Lovinger DM (1997a) Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc Natl Acad Sci USA 94:2665-70
44. Choi S, Lovinger DM (1997b) Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression. J Neurosci 17:8613-20
45. Clapham DE, Neer EJ (1997) G protein beta gamma subunits. Annu Rev Pharmacol Toxicol 37:167-203
46. Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG (2006) Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci Lett 397 (3) :180-4
47. Coutts AA, Pertwee RG (1997) Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 121 (8) :1557-66
48. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature (Lond. ) 384:83-7
49. Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G (1998) In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125 (7) :1393-5
50. Crozier RA, Wang Y, Liu CH, Bear MF (2007) Deprivation-induced synaptic depression by distinct mechanisms in different layers of mouse visual cortex. Proc Natl Acad Sci USA 2007 104 (4) :1383-8
51. Daniel H, Crepel F (2001) Control of Ca (2+) influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K (+) channels. J Physiol 537 (Pt 3) :793-800
52. Davis MI, Ronesi J, Lovinger DM (2003) A predominant role for inhibition of the adenylate cyclase/ protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells. J Biol Chem 278 (49) :48973-80
53. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-9
54. Di S, Boudaba C, Popescu IR, Weng FJ, Harris C, Marcheselli VL, Bazan NG, Tasker JG (2005) Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J Physiol 569:751-60
55. Diana MA, Marty A (2003) Characterization of depolarization-induced suppression of inhibition using paired interneuron-Purkinje cell recordings. J Neurosci 23:5906-18
56. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-91
57. Dinh TP, Carpenter D, Leslien FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99 (16) :10819-24
58. Dolphin AC (2003) G protein modulation of voltage-gated calcium channels. Pharmacol Rev 55 (4) :607-27
59. Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt HU, Zieglgansberger W, Lutz B, Rammes G (2006) Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 26 (21) :5794-9
60. Dunwiddie TV, Lovinger DM (eds. ) (1993) Presynaptic Receptors in the Mammalian Brain. Birkhauser, Boston.
61. Edwards DA, Kim J, Alger BE (2006) Multiple mechanisms of endocannabinoid response initiation in hippocampus. J. Neurophysiol. 95 (1) :67-75
62. Elmslie KS (2003) Neurotransmitter modulation of neuronal calcium channels. J Bioenerg Biomembr 35 (6) :477-89
63. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, Piomelli D (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci USA 101 (23) :8756-61
64. Feinmark SJ, Begum R, Tsetkov E, Goussakov I, Funk CD, Siegelbaum SA, Boshakov VY (2003) 12-lipoxygenase metabolites of arachidonic acid mediate metabotropic glutamate receptor-dependent long-term depression at hippocampal CA3-CA1 synapses. J Neurosci 23 (36) :11427-35
65. Flores-Hernandez J, Galarraga E, Bargas J (1997) Dopamine selects glutamatergic inputs to neostriatal neurons. Synapse 25 (2) :185-95
66. Foldy C, Neu A, Jones MV, Soltesz I (2006) Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 26 (5) :1465-9
67. Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-66
68. French ED (1997) 9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett 226:159-62
69. Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T, Kano M (2004) Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci 19:2682-92
70. Galante M, Diana MA (2004) Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production. J Neurosci 24 (20) :4865-74
71. Gardner EL, Paredes W, Smith D, Donner A, Milling C, Cohen D, Morrison D (1988) Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berl) 96:142-4
72. Gerdeman G, Lovinger DM (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85:468-71
73. Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is necessary for long-term depression in the striatum. Nat Neurosci 5 (5) :446-51
74. Gerdeman GL, Lovinger DM (2003) Emerging roles for endocannabinoids in long-term synaptic plasticity. Br J Pharmacol 140 (5) :781-9
75. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358-63
76. Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG (2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci USA 100 (7) :4269-74
77. Glass M, Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17 (14) :5327-33
78. Glass M, Northup JK (1999) Agonist selective regulation of G proteins by cannabinoid CB (1) and CB (2) receptors. Mol Pharmacol 56 (6) :1362-9
79. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102 (51) :18620-5
80. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Br Res 1071 (1) :10-23
81. Graham JD, Lewis MJ, Li DM (1974) The effect of delta1- tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat. Br J Pharmacol 52 (2) :233-6
82. Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G, Conquet F, Calabresi P (2001) Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharm 40:839-46
83. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF (2004) Segregation of two endocannabinoid-hydrolyzing enzymes into pre-and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20 (2) :441-58
84. Guo J, Ikeda SR (2004) Endocannabinoids modulate N-type calcium channels and G-proteincoupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol Pharmacol 65 (3) :665-74
85. Hajos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neurosci 106 (1) :1-4
86. Hampson RE, Deadwyler SA (1998) Role of cannabinoid receptors in memory storage. Neurobiol Dis 5 (6 Pt B) :474-82
87. Hashimotodani Y, Ohno-Shosaku T, Tsubokawa H, Ogata H, Emoto K, Maejima T, Araishi K, Shin HS, Kano M (2005) Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron 45 (2) :257-68
88. Heifets BD, Chevaleyre V, Castillo PE (2006) Interneuron activity dependence of endocannabinoid mediated long term of depression of inhibition (I-LTD) in hippocampus. Soc Neurosci Abstracts 41:12
89. Heinbockel T, Brager DH, Reich CG, Zhao J, Muralidharan S, Alger BE, Kao J (2005) Endocannabinoid signaling dynamics probed with optical tools. J Neurosci 25 (41) :9449-59
90. Hillard CJ, Jarrahian A (2000) The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem Phys Lipids 108:123-34
91. Henry DJ, Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1) by coexpressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186 (2-3) :91-4
92. Hentges ST, Low MJ, Williams JT (2005) Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. J Neurosci 25 (42) :9746-51
93. Hoffman AF, Lupica CR (2001) Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 85:72-83
94. Hoffman AF, Macgill AM, Smith D, Oz M, Lupica CR (2005) Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. Eur J Neurosci 22 (9) :2387-91
95. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435 (7045) :1108-12
96. Howlett AC, Qualy JM, Khachatrian LL (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29 (3) :307-13
97. Hsu K-T, Storch J (1996) Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms. J Biol Chem 271 (23) :13317-23
98. Huang CC, Lo SW, Hsu KS (2001) Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J Physiol 532:731-48
99. Huang YC, Wang SJ, Chiou LC, Gean PW (2003) Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. J Neurosci 23 (32) :10311-20
100. Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA, (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiat 58:322-8
101. Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME, Kunos G (1996) Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118 (8) :2023-8
102. Isokawa M, Alger BE (2005) Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell. J Physiol 567 (Pt 3) :1001-10
103. ItoM (2001) Cerebellar long-term depression: characterization, signal transduction, and functional roles. Physiol Rev 81 (3) :1143-95
104. Ito M, Kano M (1982) Long-lasting depression of parallel fiber-Purkinje cell transmission induced by conjunctive stimulation of parallel fibers and climbing fibers in the cerebellar cortex. Neurosci Lett 33:253-8
105. Jo YH, Chen YJ, Chua SC Jr, Talmage DA, Role LW (2005) Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48 (6) :1055-66
106. Jung KM, Mangieri R, Stapleton C, Kim J, Fegley D, Wallace M, Mackie K, Piomelli D (2005) Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol Pharmacol 68 (5) :1196-1202
107. Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003) Self-administration of ?9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology 169: 135-40
108. Kahn L, Alonso G, Robbe D, Bockaert J, Manzoni OJ (2001) Group 2 metabotropic glutamate receptors induced long term depression in mouse striatal slices. Neurosci Lett 316 (3) :178-82
109. Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V, Lutz B, Wotjak CT (2006) Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci 26 (25) :6677-86
110. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21 (23) :9506-18
111. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26 (21) :5628-37
112. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E,Watanabe M, Ohno-Shosaku T, Kano M (2006) The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26 (11) :2991-3001
113. Kim J, Alger BE (2004) Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7 (7) :697-8
114. Kobayashi K, Manabe T, Takahashi T (1996) Presynaptic long-term depression at the hippocampal mossy fiber-CA3 synapse. Science 273 (5275) :648-50
115. Kozak KR, Crews BC, Morrow JD, Wang LH, Ma YH, Weinander R, Jakobsson PJ, Marnett LJ (2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 277 (47) :44877-85
116. Kreitzer AC, Malenka RC (2005) Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci 25 (45) :10537-45
117. Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto purkinje cells. Neuron 29:717-27
118. Kreitzer AC, Carter AG, Regehr WG (2002) Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34:787-96
119. Kulkarni-Narla A, Brown DR (2000) Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system. Cell Tissue Res 302 (1) :73-80
120. Kushmerick C, Price GD, Taschenberger H, Puente N, Renden R, Wadiche JI, Duvoisin RM, Grandes P, von Gersdorff H (2004) Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse. J Neurosci 24 (26) :5955-65
121. Kyrozis A, Benameur K, Zhang X-L,Winterer J, MullerW, Stanton PK (2004) Retrograde messengers in long-term plasticity of presynaptic glutamate release in hippocampus. In: Stanton PK, Bramham C, Scharfman H (eds) Synaptic plasticity and transsynaptic signaling. Spinger, New York pp. 273-304
122. Laviolette SR, Grace AA (2006) Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs. J Neurosci 26 (24) :6458-68
123. Lichtman AH (2000) SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur J Pharmacol 404 (1-2) :175-9
124. Lichtman AH, Hawkins EG, Griffin G, Cravatt BF (2002) Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J Pharmacol Exp Ther 302 (1) :73-9
125. Liu J,Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R, Gong Q, Chan AC, Zhou Z, Huang B, Kim H-Y, Kunos G (2006) A biosynthetic pathway for anandamide. Proc Natl Acad Sci USA 103 (36) :13345-50
126. Llano I, Leresche N, Marty A (1991) Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 6:565-74
127. Lefkowitz RJ, Cotecchia S, Samama P, Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14 (8) :303-7
128. Levenes C, Daniel H, Soubrie P, Crepel F (1998) Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J Physiol 510:867-79
129. Lopez-Redondo F, Lees GM, Pertwee RG (1997) Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. Br J Pharmacol 122 (2) :330-4
130. Lovinger DM, Merritt A, Reyes D (1994) Involvement of N-and non-N-type calcium channels in synaptic transmission at corticostriatal synapses. Neurosci 62 (1) :31-40
131. McAllister SD, Griffin G, Satin LS, Abood ME (1999) Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. J Pharmacol Exp Ther 291 (2) :618-26
132. Maccarrone M, Bari M, Battista N, Finazzi-Agro A (2002) Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood 100:4040-8
133. McEachern JC, Shaw CA (1996) An alternative to the LTP orthodoxy: a plasticity-pathology continuum model. Brain Res Brain Res Rev 22 (1) :51-92
134. Mackie K, Lai Y, Westenbroek R, Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15 (10) :6552-61
135. Mackie K, DevaneWA, Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44 (3) :498-503
136. Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89 (9) :3825-9
137. Mackie K (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handbook Exper Pharmacol 168:299-325
138. Mackie K. (2006) Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength. Int. J. Obes. (Lond. ) 30 Suppl 1:S19-23
139. Mckinney MK, Cravatt, BP (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-32
140. Madison DV, Schuman EM (1995) Diffusible messengers and intercellular signaling: locally distributed synaptic potentiation in the hippocampus. Curr Top Microbiol Immunol 196:5-6
141. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M (2001) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31:463-75
142. Maejima T, Oka S, Hashimotodani Y, Ohno-Shosaku T, Aiba A, Wu D, Waku K, Sugiura T, Kano M (2005) Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. J Neurosci 25 (29) :6826-35
143. Makara JK, Mor M, Fegley D, Szabo SI, Kathuria S, Astarita G, Duranti A, Tontini A, Tarzia G, Rivara S, Freund TF, Piomelli D (2005) Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7 (7) :697-8
144. Makriyannis A, Guo J, Tian X (2005a) Albumin enhances the diffusion of lipophilic drugs into the membrane bilayer. Life Sci 77 (14) :1605-11
145. Makriyannis A, Tian X, Guo J (2005b) How lipophilic cannabinergic ligands reach their receptor sites. Prostaglandins Other Lipid Mediat 7 (1-4) :210-18
146. Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44 (1) :5-21
147. Mallet PE, Beninger RJ (1998) The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9- tetrahydrocannabinol or anandamide. Psychopharm (Berl. ) 140 (1) :11-19
148. Mang CF, Erbelding D, Kilbinger H (2001) Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Br J Pharmacol 134 (1) :161-7
149. Mansbach RS, Rovetti CC, Winston EN, Lowe JA 3rd. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (Berl) . 1996 Apr; 124 (4) :315-22
150. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (6897) :530-4
151. Martin LA, Alger BE (1999) Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus. Neurosci 92 (1) :61-71
152. Mato S, Robbe D, Puente N, Grandes P, Manzoni OJ (2005) Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure. J Neurosci 25 (50) :11619-627
153. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-4
154. Mazzola C, Micale V, Drago F (2003) Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol 477 (3) :219-25
155. McFarland MJ, Barker EL (2004) Anandamide transport. Pharmacol Ther 104 (2) :117-35
156. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50 (1) :83-90
157. Mechoulam R, Deutsch DG (2005) Toward an anandamide transporter. Proc Natl Acad Sci USA 102 (49) :17541-2
158. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL (2004a) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24 (1) :53-62
159. Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M (2004b) Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci 24 (47) :10707-15
160. Miller RJ (1998) Presynaptic receptors. Annu Rev Pharmacol Toxicol 38:201-27
161. Miller LL, Branconnier RJ (1983) Cannabis: effects on memory and the cholinergic limbic system. Psychol. Bull. 93 (3) :441-56
162. Mintz IM, Bean B (1993) GABAB receptor inhibition of P-type Ca2+ channels in central neurons. Neuron 10 (5) :889-98
163. Misner DL, Sullivan JM (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19:6795-6805
164. Moore SA, Nomikos GG, Dickason-Chesterfield AK, Schober DA, Schaus JM, Ying BP, Xu YC, Phebus L, Simmons RM, Li D, Iyengar S, Felder CC (2005) Identification of a highaffinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci USA 102 (49) :17852-7
165. Morishita W, Kirov SA, Alger BE (1998) Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA1. J Neurosci 18 (13) :4870-82
166. MukhtarovM, Ragozzino D, Bregestovski P (2005) Dual Ca2+ modulation of glycinergic synaptic currents in rodent hypoglossal motoneurones. J Physiol 569:817-31
167. Narasimhan K, Linden DJ (1996) Defining a minimal computational unit for cerebellar long-term depression. Neuron 17 (2) :333-41
168. Ng Cheong Ton JM, Gerhardt GA, Friedemann M, Etgen AM, Rose GM, Sharpless NS, Gardner EL (1988) The effects of delta 9-tetrahydrocannabinol on
169. Nowicky AV, Teyler TJ, Vardaris RM (1987) The modulation of LTP by delta-9-THC in the rat hippocampus in vitro. Brain Res 19:663-72
170. Ohno-Shosaku T, Maejima T, KanoM (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-38
171. Ohno-Shosaku T, Shosaku J, Tsubokawa H, KanoM (2002) Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur J Neurosci 15:953-61
172. de Oliveira Alvares L, Genro BP, Vaz Breda R, Pedroso MF, Da Costa JC, Quillfeldt JA (2006) AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats. Brain Res 1075 (1) :60-7
173. Olson PA, Tkatch T, Hernandez-Lopez S, Ulrich S, Ilijic E, Mugnaini E, Zhang H, Bezprozvanny I, Surmeier DJ (2005) G-protein-coupled receptor modulation of striatal CaV1. 3 L-type Ca2+ channels is dependent on a Shank-binding domain. J Neurosci 25 (5) :1050-62
174. Orsnes G, Crone C, Krarup C, Petersen N, Nielsen J (2000) The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients. Clin Neurophysiol 111 (8) :1372-9
175. Pan X, Ikeda SR, Lewis DL (1996) Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system. Mol Pharmacol 49 (4) :707-14
176. Pan X, Ikeda SR, Lewis DL (1998) SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 54 (6) :1064-72
177. Parolaro D, Vigano D, Rubino T (2005) Endocannabinoids and drug dependence. Curr Drug Targets CNS Neurol Disord 4:643-55
178. Perio, A, Rinaldi-Carmona, M, Maruani, J, Barth, F, Le Fur, G, Sobrie, P. Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A. Behav Pharmacol. 1996 Jan; 7 (1) :65-71
179. Pertwee RG, Fernando SR (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118 (8) :2053-8
180. Pitler TA, Alger BE (1992) Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12:4122-32
181. Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301 (3) :1020-4
182. Rancillac A, Barbara JG (2005) Frequency-dependent recruitment of inhibition mediated by stellate cells in the rat cerebellar cortex. J Neurosci Res 80 (3) :414-23
183. Ralevic V (2003) Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur J Pharmacol 472 (1-2) :1-21
184. Reisine T, Pasternak G (1996) Opioid analgesics and antagonists in Goodman & Gilman's The pharmacological basis of therapeutics. McGraw-Hill (New York, USA) pp. 521-56
185. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Sobrie P, Breliere JC, Le Fur GL (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240
186. Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 21:109-16
187. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 99:8384-8
188. Ronesi J, Gerdeman GL, Lovinger DM (2004) Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci 24 (7) :1673-9
189. Rumsey CC, Abbott LF (2006) Synaptic democracy in active dendrites. J Neurophysiol 96 (5) :2307-18
190. Saario SM, Savinainen JR, Laitinen JT, Jarvinen T, Niemi R (2004) Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 67 (7) :1381-7
191. Sacchettini JC, Gordon JI (1993) Rat intestinal fatty acid binding protein. A model system for analyzing the forces that can bind fatty acids to proteins. J Biol Chem 268:18399-402
192. Safo PK, Regehr WG (2005) Endocannabinoids control the induction of cerebellar LTD. Neuron 48:647-59
193. Sargent Jones L (2005) Recent advances in the role of integrins in developmental and adult synaptic plasticity. In: Stanton PK, Bramham C, Scharfman H (eds) Synaptic plasticity and transsynaptic signaling. Spinger, New York, pp. 457-68
194. Schmid HHO, Schmid PC, Natarajan V (1990) N-Acylated glycerophospholipids and their derivatives. Prog Lipid Res 29:1-43
195. Shiflett MW, Rankin AZ, Tomaszycki ML, DeVoogd TJ (2004) Cannabinoid inhibition improves memory in food-storing birds, but with a cost. Proc Biol Sci 271 (1552) :2043-8
196. Sjostrom PJ, Turrigiano GG, Nelson SB (2003) Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 39 (4) :641-54
197. Slanina KA, Roberto M, Schweitzer P (2005) Endocannabinoids restrict hippocampal long-term potentiation via CB1. Neuropharm 49 (5) :660-8
198. Soler-Llavina GJ, Sabatini BL (2006) Synapse-specific plasticity and compartmentalized signaling in cerebellar stellate cells. Nat Neurosci 9 (6) :798-806
199. Stanton PK, Bramham C, Scharfman H (eds) (2005) Synaptic plasticity and transsynaptic signaling. Spinger, New York pp. 457-68
200. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates longterm potentiation. Nature 388:773-8
201. Sternweiss PC, Smrcka AV, Gutowski S (1992) Hormone signalling via G-protein: regulation of phosphatidylinositol 4,5-bisphosphate hydrolysis by Gq. Philos Trans R Soc Lond B Biol Sci 336 (1276) :35-41
202. Straiker A, Mackie K (2005) Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol 569 (Pt 2) :501-17
203. Sullivan JM (2000) Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn Mem 7 (3) :132-9
204. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215 (1) :89-97
205. Sung KW, Choi S, Lovinger DM (2001) Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J Neurophysiol 86:2405-12
206. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004) Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 24 (20) :4787-95
207. Szabo B, Schlicker E (2005) Effects of cannabinoids on neurotransmission. Handbook Exper Pharmacol (168) : 327-65
208. Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Bar W, Freiman I (2006) Depolarization-induced retrograde synaptic inhibition in the cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol in press. Takahashi KA, Castillo PE (2006) The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neurosci 139 (3) :795-802
209. Takahashi RN, Pamplona FA, Fernandes MS (2005) The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci Lett 380 (3) :270-75
210. Tanda G, Pontieri FE, Di Chiara G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common 1 opioid receptor mechanism. Science 27:2048-50
211. Tanda G, Munzar P, Goldberg SR (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3:1073-4
212. Tanda G, Goldberg SR (2003) Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology 169:115
213. Tang K, Low MJ, Grandy DK, Lovinger DM (2001) Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci USA 98 (3) :1255-60
214. Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, Le Fur G, Soubrie P (1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126 (2) :165-72
215. Trettel J, Levine ES (2003) Endocannabinoids mediate rapid retrograde signaling at interneuronpyramidal neuron synapses of the neocortex. J Neurophysiol 89:2334-8
216. Trettel J, Fortin DA, Levine ES (2004) Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol 556 (Pt 1) : 95-107
217. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1997) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neurosci 83 (2) :393-411
218. Van Beugen BJ, Nagaraja RY, Hansel C (2006) Climbing fiber-evoked endocannabinoid signaling heterosynaptically suppresses presynaptic cerebellar long-term potentiation. J Neurosci 26 (32) :8289-94
219. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (5746) :329-32
220. Valjent E, Maldonado R (2000) A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) 147:436-8
221. Varma N, Carlson GC, Ledent C, Alger BE (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21:RC188
222. Varma N, Brager D, Morishita W, Lenz RA, London B, Alger B (2002) Presynaptic factors in the regulation of DSI expression in hippocampus. Neuropharm 43 (4) :550-62
223. Varvel SA, Anum EA, Lichtman AH (2005) Disruption of CB (1) receptor signaling impairs extinction of spatial memory in mice. Psychopharm 179 (4) :863-72
224. Varvel SA, Lichtman AH (2002) Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 301 (3) :915-24
225. Vincent P, Marty A (1993) Neighboring cerebellar Purkinje cells communicate via retrograde inhibition of common presynaptic interneurons. Neuron 11:885-93
226. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6 (8) :626-40
227. Wagner JJ, Alger BE (1996) Increased neuronal excitability during depolarization-induced suppression of inhibition in rat hippocampus. J Physiol 495 (1) :107-12
228. Walsh JP (1993) Depression of excitatory synaptic input in rat striatal neurons. Brain Res 608 (1) :123-8
229. Wang J, Zucker RS (2001) Photolysis-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons. J Physiol 533:757-63
230. Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger D, Surmeier DJ (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50:443-52
231. Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ (1995) The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 359 (2-3) :133-6
232. Wei BQ, Mikkelsen TS, McKinney MK, Lander ES, Cravatt BF (2006) A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem 281 (48) : 36569-78
233. Weisskopf MG, Zalutsky RA, Nicoll RA (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362 (6419) :423-7
234. Wigstrom H, Gustafsson B (1986) Postsynaptic control of hippocampal long-term potentiation. J Physiol (Paris) 81 (4) :228-36
235. Wiley JL, Martin BR (1999) Effects of SR141716A on diazepam substitution for delta9-tetrahydrocannabinol in rat drug discrimination. Pharmacol Biochem Behav 64:519
236. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-92
237. Wilson RI, Kunos G. Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31 (3) :453-62
238. Wolf MC, Leander JD (2003) SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. Eur J Pharmacol 477 (3) :213-17
239. Wu L-G, Saggau P (1997) Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20 (5) : 204-12
240. Yanovsky Y, Mades S, Misgeld U (2003) Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra. Neurosci 122:317-238
241. Yin HH, Ronesi J, Davis M, Lovinger DM (2006) The role of protein synthesis in striatal long-term depression. J Neurosci 26 (46) :11811-20
242. Yin HH, Lovinger DM (2006) Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci USA 103 (21) : 8251-6
243. Yoshida T, Hashimoto K, Zimmer A, Maejima T, Araishi K, Kano M (2002) The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J Neurosci 22 (5) :1690-7
244. Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA (2006) Two brain sites for cannabinoid reward. J Neurosci 26 (18) :4901-7
245. Zhu PJ, Lovinger DM (2005) Retrograde endocannabinoid signaling in a postsynaptic neuron/ synaptic bouton preparation from basolateral amygdala. J Neurosci 25 (26) :6199-6207